Victor Bartsevich is a Ph.D. biologist with 20 years of experience in the biotechnology industry, specializing in gene editing technologies and CAR-T therapies. They have held various positions, including Scientist II at Sangamo BioSciences, where they developed zinc finger protein technology, and Director of Emerging Technologies Development at Precision Biosciences, focusing on gene editing and antibody development. Currently, Victor is at Life Edit Therapeutics, working on CRISPR-based gene editing technologies and therapies. They earned a Ph.D. in Genetics from the N. Vavilov Institute of General Genetics and a Master's in Physics from The National Research Nuclear University.